Furthermore, it has been demonstrated by other researchers that the persistent activation of TLR7, which is expressed by multipotent CD133+ colon cancer‐initiating cells and tumor cells from CRC, sustains the inflammatory response, facilitates resistance to apoptosis, and encourages the growth of new tumors.286. This evidence concerns the gene TLR7 and malignant colon neoplasm.